A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.
暂无分享,去创建一个
Feng Liu | Matthew T Haynes | Leaf Huang | F. Liu | Yuhua Wang | Leaf Huang | Yunxia Hu | Matthew T. Haynes | Yunxia Hu | Yuhua Wang | Feng Liu
[1] Vladimir P Torchilin,et al. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.
[2] K. L. Douglas. Toward Development of Artificial Viruses for Gene Therapy: A Comparative Evaluation of Viral and Non‐viral Transfection , 2008, Biotechnology progress.
[3] Yuma Yamada,et al. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. , 2008, Advanced drug delivery reviews.
[4] Yang Liu,et al. In vivo delivery of RNAi with lipid-based nanoparticles. , 2011, Annual review of biomedical engineering.
[5] Leaf Huang,et al. Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[6] F. Szoka,et al. Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.
[7] D. Perry. Factor VII deficiency. , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[8] R. Pierce,et al. Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo , 2009, Nucleic acids research.
[9] A. Villaverde,et al. Modular protein engineering for non-viral gene therapy. , 2004, Trends in biotechnology.
[10] H Akita,et al. Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery , 2007, Gene Therapy.
[11] Yaping Li,et al. Linear cationic click polymers/DNA nanoparticles: in vitro structure-activity relationship and in vivo evaluation for gene delivery. , 2011, Bioconjugate chemistry.
[12] L. Chernomordik,et al. Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery , 2005, Cellular and Molecular Life Sciences CMLS.
[13] P. Cullis,et al. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.
[14] S. W. Kim,et al. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. , 2009, Biomaterials.
[15] Dexi Liu,et al. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.
[16] Biodistribution Studies of Nanoparticles Using Fluorescence Imaging: A Qualitative or Quantitative Method? , 2012, Pharmaceutical Research.
[17] V. Puntes,et al. Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting. , 2012, ACS nano.
[18] Munia Ganguli,et al. Differences in DNA condensation and release by lysine and arginine homopeptides govern their DNA delivery efficiencies. , 2011, Molecular pharmaceutics.
[19] W. Saltzman,et al. Enzyme-synthesized poly(amine-co-esters) as nonviral vectors for gene delivery. , 2011, Journal of biomedical materials research. Part A.
[20] Minhyung Lee,et al. Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[21] Kostas Kostarelos,et al. Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. , 2011, Biomaterials.
[22] J. Prakash,et al. Drug targeting to the diseased liver. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[23] E. Wisse,et al. Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae , 2007, Gene Therapy.
[24] Kam W. Leong,et al. Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery , 2010, Journal of The Royal Society Interface.
[25] Robert Langer,et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.
[26] D. Oupický,et al. Multiblock reducible copolypeptides containing histidine-rich and nuclear localization sequences for gene delivery. , 2006, Bioconjugate chemistry.
[27] Kathryn A. Whitehead,et al. Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.
[28] H. Harashima,et al. Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus , 2009, The AAPS Journal.
[29] Wim E. Hennink,et al. Artificial viruses: a nanotechnological approach to gene delivery , 2006, Nature Reviews Drug Discovery.
[30] T. V. van Berkel,et al. Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytesin Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.
[31] A. Klibanov,et al. Highly Effective Gene Transfection In Vivo by Alkylated Polyethylenimine , 2011, Journal of drug delivery.
[32] K. Leong,et al. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[33] S. Brüsselbach,et al. Highly efficient transduction of endothelial cells by targeted artificial virus-like particles , 2001, Cancer Gene Therapy.
[34] Yaping Li,et al. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency. , 2008, International journal of pharmaceutics.
[35] A. Villaverde,et al. Nonviral gene delivery to the central nervous system based on a novel integrin-targeting multifunctional protein. , 2003, Human gene therapy.
[36] Y. Maitani,et al. Calcium enhanced delivery of tetraarginine-PEG-lipid-coated DNA/protamine complexes. , 2009, International journal of pharmaceutics.
[37] I. Khalil,et al. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[38] Wim E Hennink,et al. Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells , 2001, Cancer Gene Therapy.
[39] Sumati Sundaram,et al. Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. , 2004, Annual review of biomedical engineering.
[40] Darren H. Wakefield,et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes , 2007, Proceedings of the National Academy of Sciences.
[41] Yu Chen,et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. , 2012, Journal of the American Chemical Society.
[42] M. Schilsky. Wilson disease: New insights into pathogenesis, diagnosis, and future therapy , 2005, Current gastroenterology reports.
[43] S. Futaki,et al. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. , 2008, Advanced drug delivery reviews.
[44] D. Stolz,et al. Bifunctional compounds for targeted hepatic gene delivery , 2007, Gene Therapy.
[45] I. N. Crispe,et al. Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.
[46] T. Flotte,et al. Gene therapy for alpha-1 antitrypsin deficiency. , 2011, Human molecular genetics.
[47] Jason L. Townson,et al. Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers. , 2012, ACS nano.
[48] T. Niidome,et al. Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.
[49] E. Smiley,et al. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. , 2000, Bioconjugate chemistry.